Sedana Medical submits IND for US clinical trials

/PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the company has submitted an Investigational New Drug (IND) application to...

Related Keywords

Germany ,Australia ,United States ,Stockholm ,Sweden ,United Kingdom ,Canada ,France ,Spain ,America ,Great Britain ,Susanne Andersson ,Certified Adviser Is Erik Penser Bank ,Drug Administration ,Investigational New Drug ,Sedana Medical ,Johannes Doll ,Nasdaq First North Growth Market ,Certified Adviser ,Erik Penser Bank ,Central America ,